Future large, multicenter, longitudinal studies with standardized assays are needed to validate its prognostic value and clarify the mechanistic role of the OPG/RANK/RANKL axis, which could ultimately inform risk stratification and therapeutic approaches in HF. This evidence concerns the gene TNFRSF11A and hydrops fetalis.